Total pancreatectomy: indications, operative technique, and postoperative sequelae.
Total pancreatectomy has been used to treat both benign and malignant disease of the pancreas, but its use has been limited by concerns about management of the a-pancreatic state with its attendant total endocrine and exocrine insufficiency. Here, we review the indications for total pancreatectomy, operative technique, and improvements in the postoperative management of patients. Total pancreatectomy remains a viable option in the treatment of intractable pain associated with chronic pancreatitis, multicentric or extensive neuroendocrine tumors, patients with familial pancreatic cancer with premalignant lesions, and in patients with intraductal papillary mucinous neoplasia with diffuse ductal involvement or invasive disease. Improvements in postoperative management include auto-islet cell transplantation, advances in insulin formulations, and the use of glucagon rescue therapy which allow much tighter control of blood glucose than previously possible. This markedly lessens the risk of life-threatening hypoglycemia and decreases the risk of long-term complications, resulting in improved quality of life for these patients.
Heidt
David G
DG
Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA.
Burant
Charles
C
Simeone
Diane M
DM
D002908:Chronic Disease; D010188:Exocrine Pancreatic Insufficiency / Q000209:etiology / Q000628:therapy; D005234:Fatty Liver / Q000209:etiology / Q000628:therapy; D006801:Humans; D017093:Liver Failure / Q000209:etiology / Q000628:therapy; D010148:Intractable Pain / Q000209:etiology / Q000601:surgery; D010180:Pancreatectomy / Q000009:adverse effects / Q000379:methods; D010190:Pancreatic Neoplasms / Q000601:surgery; D010195:Pancreatitis / Q000150:complications / Q000601:surgery; D011788:Quality of Life